These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11925113)

  • 1. Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer.
    Andersen MR; Peacock S; Nelson J; Wilson S; McIntosh M; Drescher C; Urban N
    Gynecol Oncol; 2002 Apr; 85(1):3-8. PubMed ID: 11925113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in cancer worry associated with participation in ovarian cancer screening.
    Andersen MR; Drescher CW; Zheng Y; Bowen DJ; Wilson S; Young A; McIntosh M; Mahony BS; Lowe KA; Urban N
    Psychooncology; 2007 Sep; 16(9):814-20. PubMed ID: 17225260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Underestimation of breast cancer risk: influence on screening behavior.
    Katapodi MC; Dodd MJ; Lee KA; Facione NC
    Oncol Nurs Forum; 2009 May; 36(3):306-14. PubMed ID: 19403452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer worry and mammography use by women with and without a family history in a population-based sample.
    Andersen MR; Smith R; Meischke H; Bowen D; Urban N
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):314-20. PubMed ID: 12692105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
    Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
    Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women at risk of ovarian cancer.
    Wardle J
    J Natl Cancer Inst Monogr; 1995; (17):81-5. PubMed ID: 8573460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer worry in women with hereditary risk factors for breast cancer.
    Loescher LJ
    Oncol Nurs Forum; 2003; 30(5):767-72. PubMed ID: 12949589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women's awareness of ovarian cancer risks and symptoms.
    Lockwood-Rayermann S; Donovan HS; Rambo D; Kuo CW
    Am J Nurs; 2009 Sep; 109(9):36-45; quiz 46. PubMed ID: 19704232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological adjustment to familial-genetic risk assessment for ovarian cancer: predictors of nonadherence to surveillance recommendations.
    Ritvo P; Irvine J; Robinson G; Brown L; Murphy KJ; Matthew A; Rosen B
    Gynecol Oncol; 2002 Jan; 84(1):72-80. PubMed ID: 11748980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center.
    Muto MG; Cramer DW; Brown DL; Welch WR; Harlow BL; Xu H; Brucks JP; Tsao SW; Berkowitz RS
    Gynecol Oncol; 1993 Oct; 51(1):12-20. PubMed ID: 8244166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.
    Skates SJ; Menon U; MacDonald N; Rosenthal AN; Oram DH; Knapp RC; Jacobs IJ
    J Clin Oncol; 2003 May; 21(10 Suppl):206s-210s. PubMed ID: 12743136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciding about prophylactic oophorectomy: what is important to women at increased risk of ovarian cancer?
    Fry A; Rush R; Busby-Earle C; Cull A
    Prev Med; 2001 Dec; 33(6):578-85. PubMed ID: 11716653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer worry is associated with abnormal prostate-specific antigen levels in men participating in a community screening program.
    Cohen L; Fouladi RT; Babaian RJ; Bhadkamkar VA; Parker PA; Taylor CC; Smith MA; Gritz ER; Basen-Engquist K
    Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):610-7. PubMed ID: 12869399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coping with ovarian cancer risk: the moderating effects of perceived control on coping and adjustment.
    Fang CY; Daly MB; Miller SM; Zerr T; Malick J; Engstrom P
    Br J Health Psychol; 2006 Nov; 11(Pt 4):561-80. PubMed ID: 17032484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of breast cancer-related distress following mammography screening in younger women on a family history breast screening programme.
    Brain K; Henderson BJ; Tyndel S; Bankhead C; Watson E; Clements A; Austoker J;
    Psychooncology; 2008 Dec; 17(12):1180-8. PubMed ID: 18506670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based screening for hereditary breast cancer in a region of North-Central Italy.
    Casadei S; Falcini F; Naldoni C; Amadori D; Calistri D
    Int J Mol Med; 2002 Sep; 10(3):299-305. PubMed ID: 12165804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of a decision aid for women at increased risk of ovarian cancer.
    Tiller K; Meiser B; Gaff C; Kirk J; Dudding T; Phillips KA; Friedlander M; Tucker K
    Med Decis Making; 2006; 26(4):360-72. PubMed ID: 16855125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer risk factors and second primary malignancies among women with breast cancer.
    Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
    Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for ovarian cancer-risk, education, worry: path to appropriate use?
    Skates SJ
    Gynecol Oncol; 2002 Apr; 85(1):1-2. PubMed ID: 11925112
    [No Abstract]   [Full Text] [Related]  

  • 20. Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study.
    Jacobi CE; Nagelkerke NJ; van Houwelingen JH; de Bock GH
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):429-36. PubMed ID: 16537697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.